Geron (GERN) Total Debt (2011 - 2026)
Geron (GERN) posted Total Debt of $119.8 million for Q1 2026, little changed sequentially from $119.5 million in Q4 2025, and up 0.93% YoY from $118.7 million in Q1 2025.
Geron (GERN) Total Debt (2011 - 2026) Analysis & Trends
Geron has reported Total Debt for 9 years, with the latest figure at $119.8 million in Q1 2026.
- Quarterly Total Debt rose 0.93% year-over-year to $119.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $119.8 million (up 0.93% YoY) and the FY2025 annual result came in at $119.5 million, up 0.9% from the prior year.
- Total Debt held at $119.8 million in Q1 2026 per GERN's latest filing, from $119.5 million in the prior quarter.
- Over five years, Total Debt peaked at $119.8 million in Q1 2026 and troughed at $50.2 million in Q1 2022.
- A 5-year average of $82.6 million and a median of $82.7 million in 2024 frame the typical range for Total Debt.
- The sharpest annual moves came in 2022 and 2025: Total Debt soared 107.16% in 2022, then increased 0.9% in 2025.
- Over 5 years, Total Debt stood at $51.2 million in 2022, then surged by 60.18% to $81.9 million in 2023, then surged by 44.58% to $118.5 million in 2024, then increased by 0.9% to $119.5 million in 2025, then rose by 0.24% to $119.8 million in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $119.8 million, $119.5 million, and $119.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - | 9.34 Bn |
| 10 | Geron | 1.05 Mn | -299.80 Mn | - | 120.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 120.13 Mn |
| Mar 31, 2026 | 119.83 Mn |
| Dec 31, 2025 | 119.55 Mn |
| Sep 30, 2025 | 119.26 Mn |
| Jun 30, 2025 | 118.99 Mn |
| Mar 31, 2025 | 118.73 Mn |
| Dec 31, 2024 | 118.48 Mn |
| Sep 30, 2024 | 83.84 Mn |
| Jun 30, 2024 | 83.44 Mn |
| Mar 31, 2024 | 82.75 Mn |
| Dec 31, 2023 | 81.94 Mn |
| Sep 30, 2023 | 51.90 Mn |
| Jun 30, 2023 | 51.64 Mn |
| Mar 31, 2023 | 51.40 Mn |
| Dec 31, 2022 | 51.16 Mn |
| Sep 30, 2022 | 50.76 Mn |
| Jun 30, 2022 | 50.42 Mn |
| Mar 31, 2022 | 50.18 Mn |
| Dec 31, 2021 | 49.83 Mn |
| Sep 30, 2021 | 34.67 Mn |